FDA Inspection 604811 — Carter BloodCare

Carter BloodCare — FEI 3002603147

The FDA completed an inspection of Carter BloodCare on August 17, 2009 in Bedford, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 17, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bedford, TX (United States)